(Q40728326)

English

In vitro studies of core peptide-bearing immunopotentiating reconstituted influenza virosomes as a non-live prototype vaccine against hepatitis C virus

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

In vitro studies of core peptide-bearing immunopotentiating reconstituted influenza virosomes as a non-live prototype vaccine against hepatitis C virus (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Hepatitis C virus

1 reference

based on heuristic

inferred from title

author name string

Isabelle P Hunziker

1

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Benno Grabscheid

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Rinaldo Zurbriggen

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Reinhard Glück

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Werner J Pichler

5

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Andreas Cerny

6

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

publication date

1 June 2002

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

International Immunology

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

615-626

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Formation of virosomes from influenza subunits and liposomes

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXF026

21 January 2018

Canarypox virus-induced maturation of dendritic cells is mediated by apoptotic cell death and tumor necrosis factor alpha secretion

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXF026

21 January 2018

Virosomes reconstituted from human immunodeficiency virus proteins and lipids

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXF026

21 January 2018

Engineered liposomes and virosomes for delivery of macromolecules

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXF026

21 January 2018

Development of a new type of influenza subunit vaccine made by muramyldipeptide-liposome: enhancement of humoral and cellular immune responses

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXF026

21 January 2018

Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXF026

21 January 2018

Preparation, properties, and applications of reconstituted influenza virus envelopes (virosomes).

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXF026

21 January 2018

The structure and function of the hemagglutinin membrane glycoprotein of influenza virus

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXF026

21 January 2018

Membrane Fusion by Peptide Analogues of Influenza Virus Haemagglutinin

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXF026

21 January 2018

Three antibody molecules can bind simultaneously to each monomer of the tetramer of influenza virus neuraminidase and the trimer of influenza virus hemagglutinin

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXF026

21 January 2018

Structure-function relationships among highly diverse T cells that recognize a determinant from influenza virus hemagglutinin

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXF026

21 January 2018

T cell priming versus T cell tolerance induced by synthetic peptides

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXF026

21 January 2018

Immunogenicity and adverse effects of inactivated virosome versus alum-adsorbed hepatitis A vaccine: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXF026

21 January 2018

Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXF026

21 January 2018

Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXF026

21 January 2018

Sequence analysis of the hepatitis C virus (HCV) core gene suggests the core protein as an appropriate target for HCV vaccine strategies

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXF026

21 January 2018

Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXF026

21 January 2018

Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2.

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXF026

21 January 2018

Homozygous deletions that simultaneously eliminate expressions of class I and class II antigens of EBV-transformed B-lymphoblastoid cells. I. Reduced proliferative responses of autologous and allogeneic T cells to mutant cells that have decreased ex

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXF026

21 January 2018

Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids.

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXF026

21 January 2018

Transporter (TAP)-independent processing of a multiple membrane-spanning protein, the Epstein-Barr virus latent membrane protein 2.

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXF026

21 January 2018

Induction in vitro of a primary human antiviral cytotoxic T cell response

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXF026

21 January 2018

A simple method to eliminate the antigenicity of surface class I MHC molecules from the membrane of viable cells by acid treatment at pH 3.

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXF026

21 January 2018

High efficiency prokaryotic expression and purification of a portion of the hepatitis C core protein and analysis of the immune response to recombinant protein in BALB/c mice

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXF026

21 January 2018

Brefeldin A implicates egress from endoplasmic reticulum in class I restricted antigen presentation

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXF026

21 January 2018

HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXF026

21 January 2018

HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXF026

21 January 2018

Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I-restricted cell-mediated lysis

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXF026

21 January 2018

Transporter-independent processing of HIV-1 envelope protein for recognition by CD8+ T cells

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXF026

21 January 2018

Glycan-regulated antigen processing of a protein in the endoplasmic reticulum can uncover cryptic cytotoxic T cell epitopes

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXF026

21 January 2018

Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXF026

21 January 2018

Serial triggering of many T-cell receptors by a few peptide-MHC complexes

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXF026

21 January 2018

Safety, immunogenicity, and kinetics of the immune response to a single dose of virosome-formulated hepatitis A vaccine in Thais

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXF026

21 January 2018

Identifiers

10.1093/INTIMM/DXF026

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40728326&oldid=1905202599"